Multiple Myeloma an incurable disease, but I have spent the last 25 years in remission using a blend of conventional oncology and evidence-based nutrition, supplementation, and lifestyle therapies from peer-reviewed studies that your oncologist probably hasn't told you about.
Click the orange button to the right to learn more about what you can start doing today.
Multiple myeloma (MM) is an incurable blood cancer. Conventional FDA approved MM therapies can induce one or more remissions however almost all MMer eventually relapse and face MDR or multi-drug resistance. I believe all MM survivors must consider non-conventional, non-toxic multiple myeloma therapy such as ellagic acid.
Newly diagnosed MMers need more than what conventional oncology offers. Evidence-based but non-conventional integrative, non-conventional and complementary therapies offer greater possibilities.
Nutritional supplementation such as ellagic acid and pomegranate should be regarded as an ideal adjunct therapy for the newly diagnosed multiple myeloma patient as well as the MMer who is in remission.
Conventional oncology must focus on FDA approved cancer therapies by law. This is the way that conventional medicine works. And that system is fine for those diseases that are addressed properly by conventional medicine. Unfortunately, MM is not one of those diseases.
Have you been diagnosed with multiple myeloma? What stage? What therapies have you undergone or are you considering?
To learn more about these and other integrative therapies please scroll down the page, post a question or comment and I will reply ASAP.
“I have not come across any studies specifically linking ellagic acid, or ellagitannins (the difference is explained below), to myeloma, but its anti-cancer properties are well-established, at least in vitro and in vivo on cells, rats and mice. I would like to mention that the University of Oslo is currently conducting a clinical trial on ellagic acid and other substances (quercetin, selenium, garlic extract, EGCG, etc.) for follicular lymphoma..”
“Abstract: The last 7 years have seen over seven times as many publications indexed by Medline dealing with pomegranate and Punica granatum than in all the years preceding them. Because of this, and the virtual explosion of interest in pomegranate as a medicinal and nutritional product that has followed, this review is accordingly launched.
The pomegranate tree, Punica granatum, especially its fruit, possesses a vast ethnomedical history and represents a phytochemical reservoir of heuristic medicinal value. The tree/fruit can be divided into several anatomical compartments: (1) seed, (2) juice, (3) peel, (4) leaf, (5) flower, (6) bark, and (7) roots, each of which has interesting pharmacologic activity. Juice and peels, for example, possess potent antioxidant properties, while juice, peel and oil are all weakly estrogenic and heuristically of interest for the treatment of menopausal symptoms and sequellae.
The use of juice, peel and oil have also been shown to possess anticancer activities, including interference with tumor cell proliferation, cell cycle, invasion and angiogenesis. These may be associated with plant based anti-inflammatory effects, The phytochemistry and pharmacological actions of all Punica granatum components suggest a wide range of clinical applications for the treatment and prevention of cancer, as well as other diseases where chronic inflammation is believed to play an essential etiologic role.”
“Abstract: To determine the effect of ellagic acid on apoptosis and proliferation in pancreatic cancer cells and to determine the mechanism of the pro-survival effects of ellagic acid.
RESULTS: We show that ellagic acid, a polyphenolic compound in fruits and berries, at concentrations 10 to 50 mmol/L stimulates apoptosis in human pancreatic adenocarcinoma cells. Further, ellagic acid decreases proliferation by up to 20-fold at 50 mmol/L…”